Test Overview
Clinical Utility
Aripiprazole (Abilify®) is an atypical antipsychotic and antidepressant used in the treatment of schizophrenia, bipolar disorder, and clinical depression. The analysis of aripiprazole is used to monitor compliance with drug therapy.
Method
Chromatography/Mass Spectrometry
Result Included
Aripiprazole
Aliases/Synonyms
Abilify®
Specimen
Specimen Type
Avoid gel separator tubesSerum
Plasma (EDTA)
Containers
Preferred Containers
Red top (no additive)
Acceptable Containers
Lavender top (EDTA)
Volume
Sample Volume
3 mL
Minimum Volume
0.5 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 7 days | 14 days | 30 days |
Rejection Criteria
| Criteria | Specification |
|---|---|
| Specimen | Gel-separator tube |
Performance & Interpretation
Turnaround Time
9 days
Results
Name
Units
Reference Range
Conversion
-
Aripirazoleng/mLSee comment below
Comment
Steady state plasma levels in adults following a daily regimen have been reported as:
- 5 mg 70 to 126
- 10 mg 109 to 216
- 15 mg 206 to 278
- 20 mg 212 to 574
- 30 mg 320 to 585
Referral Location
Out-of-Country
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| ARIP | ARIPIPRAZOLE, QN, SERUM/PLASMA | 63006 | ng/mL |
Test Version
Last Updated
2023-01-19